Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
2017 · JAMA · 2,455 citations
https://doi.org/10.1001/jama.2017.18718
S
Steven A. Toms
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
431
Papers
11.3K
Citations
44
h-index
127
i10-index
Steven A. Toms is an academic researcher. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Brain Metastases and Treatment & Historical Economic and Social Studies. The author has an h-index of 44, co-authored 367 publications.
ORCID: 0000-0001-8732-0522Papers by this author
worksFirst results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
2018 · Journal of Translational Medicine · 528 citations
https://doi.org/10.1186/s12967-018-1507-6
Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial
2018 · Journal of Neuro-Oncology · 166 citations
https://doi.org/10.1007/s11060-018-03057-z
Chi3l1 Is a Modulator of Glioma Stem Cell States and a Therapeutic Target in Glioblastoma
2023 · Cancer Research · 91 citations
https://doi.org/10.1158/0008-5472.can-21-3629
The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF™-100A system
2014 · World Journal of Surgical Oncology · 34 citations
https://doi.org/10.1186/1477-7819-12-162
Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
2018 · Journal of Translational Medicine · 17 citations
https://doi.org/10.1186/s12967-018-1552-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat